ArticleJHEP reports : innovation in hepatology2025
Disparate patterns of disease time burden in patients with HCC on immunotherapy or tyrosine kinase inhibitors.
Rex Wan-Hin Hui et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it